Wegovy® 1.7 mg is a higher dose in the once-weekly injectable treatment plan for chronic weight management in adults and adolescents with obesity or overweight-related health conditions. Each prefilled pen delivers 1.7 mg of semaglutide in 0.5 mL, designed to be used once weekly. This dose is typically reached after completing previous steps in the titration schedule (0.25 mg, 0.5 mg, and 1 mg) and is intended to maximize weight loss while continuing to manage hunger and appetite.

Features:

• Higher Dose for Maximum Results: 1.7 mg is the third step in the Wegovy titration plan, designed to support greater weight loss.

• Once-Weekly Dosing: Convenient weekly injections to help patients stay consistent with their weight loss journey.

• Prefilled, Ready-to-Use Pens: No mixing required—just one-step injection with no visible needle.

• GLP-1 Receptor Agonist: Semaglutide works by reducing appetite and food intake, contributing to sustained weight loss.

• 4-Pack for 4 Weeks: Provides one pen for each week of treatment during the dose escalation phase.